The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
about
Interactions between Myc and Mediators of Inflammation in Chronic Liver DiseasesAdvances in cholangiocyte immunobiologyGP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epitheliumBiliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver diseaseDeletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisImpact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.Foxa1 and Foxa2 regulate bile duct development in mice.NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism.Oroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury miceAnimal models for the study of liver fibrosis: new insights from knockout mouse models.Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal liversHepatocyte growth factor attenuates liver fibrosis induced by bile duct ligationRegulation and function of trefoil factor family 3 expression in the biliary tree.Steatosis: co-factor in other liver diseases.Hepatoprotective effects of baicalein against CCl₄-induced acute liver injury in mice.Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical CarcinogenesisInterleukin‑6 induces epithelial‑mesenchymal transition in human intrahepatic biliary epithelial cells.Wound healing in the biliary tree of liver allografts.Preexisting epithelial diversity in normal human livers: a tissue-tethered cytometric analysis in portal/periportal epithelial cells.Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice.Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP.Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in miceEndocrine and paracrine role of bile acidsInvolvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis.Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation.Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes.Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients.Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.Endogenous interferon gamma protects against cholestatic liver injury in mice.Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.Antifibrotic Effects of Human Amniotic Membrane Transplantation in Established Biliary Fibrosis Induced in Rats.Rapamycin inhibits cholangiocyte regeneration by blocking interleukin-6-induced activation of signal transducer and activator of transcription 3 after liver transplantation.Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes.Characterization of time-related changes after experimental bile duct ligation.Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity.The Cholangiocyte Adenosine-IL-6 Axis Regulates Survival During Biliary Cirrhosis.Interleukin-6 promotes the migration and cellular senescence and inhibits apoptosis of human intrahepatic biliary epithelial cells.
P2860
Q26778328-B1F34270-A67F-4B2F-822C-615014C3E486Q27002954-CE3FC09E-C06D-43AF-8D7C-686D62E6F825Q30482145-A28C119A-E337-4B57-ABEA-150214DAFF71Q33866788-36D920C4-A927-40D7-933D-AFB635EC836EQ34116480-CA12F56C-F6E5-42F8-BC18-516D78520791Q34345002-47425F61-A73D-476F-9F29-A9203FC910FAQ34658511-97F8F56F-C140-4B2D-A891-75AD28A04755Q34699432-6060FAED-FE72-429F-93D3-2157D939CDA7Q34950079-5A04302E-CEA9-4795-AE4B-87D2752B98BBQ34979933-3704F565-B395-4FDC-8BDA-1E7B81D312DDQ35062521-F356C751-9091-4B8E-84F5-0AA9779C2A18Q35088302-2CB9035E-FC25-48AD-8B1A-F25EDB429B6DQ35103575-5844A630-1C39-4DEA-9F8F-8855BB7CF067Q36165987-AB4F0C81-D12D-4F40-95D7-86DD6156A915Q36450452-1902D526-A445-4523-849C-CD92B4269001Q36509078-6902B0D2-69F0-4717-8F7F-70D08076A35BQ36520248-B68A4743-01A2-4824-A408-DD7F349A7FE8Q36529994-D721636A-5FF4-45F8-8661-27787AA106E0Q36728853-4B9C9FFB-A737-48D5-9CED-F6DAFFF3AFC2Q36794471-642642D8-2247-4C1E-BC9B-8471B7DD7B1AQ36846473-36257AFE-B3B9-4FF7-8318-6DBB16F5A06EQ37138776-79EEB2E0-09C1-4DEB-B612-E2B17C77F51DQ37278165-1F6C4568-46A6-4EC4-9F88-0E788ABCC7BAQ37287593-F7234F58-5C3A-4497-9BCA-E3D48C50C5EFQ37362062-F2B1E437-510A-431F-B501-2F10398BA7EFQ38333967-6F3C30C2-EC31-465F-80F3-6D9E155B369AQ38809882-CCF596E2-1242-4277-BB6F-87FBD73BB02CQ39138286-3D4E2E52-F545-4662-9910-7B0F13FB186DQ39446750-6D40736F-286D-47BD-A1C4-070EABF146B2Q39448087-24C409CC-E1EF-404C-9160-1C46D14EFB7CQ40214323-2AA298BD-0F6F-4D1E-8C8E-DA396EEA2F87Q40216755-C4A3F91B-895F-4746-BC97-B2CF558D2196Q40243986-F68D5787-CA4F-432C-BAE8-CF4B646FFC21Q40394506-AB20F183-EE43-4ECF-9178-1B63D67A0013Q43183166-40426BCC-F8A5-40FD-AC43-FD817867DF85Q46249434-AA231BC2-7B94-43CB-ACA8-6765889EF29EQ46807443-F583553B-C99F-4ED3-8C51-99C1762917A8Q46952190-15E2CEDF-9DEA-43B0-90FF-01432FE979CDQ47821845-CA4FAB59-F048-4470-8D42-D362273F66A9Q47878562-6DFDE02B-F13F-40CE-B9D9-965CCF2BE4B4
P2860
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@ast
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@en
type
label
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@ast
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@en
prefLabel
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@ast
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@en
P2093
P2860
P1476
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65034-1
P407
P577
2000-05-01T00:00:00Z